Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Rectal Neoplasms 11 Glioblastoma 10 Breast Neoplasms 10 Lung Neoplasms 9 Head and Neck Neoplasms 8 Neoplasms 6 Neoplasm Metastasis 6 Brain Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Prostatic Neoplasms 5 Leukemia 4 Gliosarcoma 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Carcinoma, Merkel Cell 3 Adenocarcinoma Of Esophagus 3 Xerostomia 2 Waldenstrom Macroglobulinemia 2 Small Cell Lung Carcinoma 2 Recurrence 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2

Interventions

Rituximab 66 Cyclophosphamide 52 fludarabine phosphate 26 fludarabine 22 Filgrastim 21 Vincristine 19 Methotrexate 19 Melphalan 19 Doxorubicin 18 Radiotherapy 17 Etoposide 17 Prednisone 16 Tacrolimus 15 Whole-Body Irradiation 14 Mycophenolic Acid 14 Cytarabine 14 Peripheral Blood Stem Cell Transplantation 13 Gemcitabine 13 Cyclosporine 13 Antilymphocyte Serum 13 Lenalidomide 12 Busulfan 11 Bortezomib 11 Granulocyte Colony-Stimulating Factor 9 Alemtuzumab 9 sargramostim 8 Dexamethasone 8 Cord Blood Stem Cell Transplantation 8 pembrolizumab 7 ibritumomab tiuxetan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphoma × Radiation × Clear all

NCT01321008 2015-02-05

Stage I/II Nasal NK Cell Lymphoma

M.D. Anderson Cancer Center

Phase 1/2 Terminated

1 enrolled 3 charts

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡